VAMOROLONE (Agamree)
Clinical Indication
Duchenne muscular dystrophy in people 4 years and over
Comments
In line with NICE TA1031.
Date of classification
May 2025
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.